These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38103822)

  • 21. Current Practice of State-of-the-Art Coronary Revascularization in Patients with Heart Failure.
    Rayol SC; Sá MPBO; Cavalcanti LRP; Saragiotto FAS; Diniz RGS; Sá FBCAE; Menezes AM; Lima RC
    Braz J Cardiovasc Surg; 2019; 34(1):93-97. PubMed ID: 30810680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ten-Year Outcomes After Coronary Artery Bypass Grafting According to Age in Patients With Heart Failure and Left Ventricular Systolic Dysfunction: An Analysis of the Extended Follow-Up of the STICH Trial (Surgical Treatment for Ischemic Heart Failure).
    Petrie MC; Jhund PS; She L; Adlbrecht C; Doenst T; Panza JA; Hill JA; Lee KL; Rouleau JL; Prior DL; Ali IS; Maddury J; Golba KS; White HD; Carson P; Chrzanowski L; Romanov A; Miller AB; Velazquez EJ;
    Circulation; 2016 Nov; 134(18):1314-1324. PubMed ID: 27573034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous coronary intervention among patients with left ventricular systolic dysfunction: a review and meta-analysis of 19 clinical studies.
    Kunadian V; Pugh A; Zaman AG; Qiu W
    Coron Artery Dis; 2012 Nov; 23(7):469-79. PubMed ID: 22960383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Different revascularization strategies for patients with coronary artery disease complicating reduced ejection fraction].
    Lyu Y; Liu JH; Wang SP; Zheng Z; Wu Z
    Zhonghua Yi Xue Za Zhi; 2021 Jul; 101(26):2071-2076. PubMed ID: 34275241
    [No Abstract]   [Full Text] [Related]  

  • 25. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding the role of coronary artery revascularization in patients with left ventricular dysfunction and multivessel disease.
    Acerbo V; Cesaro A; Scherillo G; Signore G; Rotolo FP; De Michele G; Scialla F; Raucci G; Panico D; Fimiani F; Moscarella E; Gragnano F; Calabrò P
    Heart Fail Rev; 2023 Nov; 28(6):1325-1334. PubMed ID: 37493869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Heart Failure on Long-Term Clinical Outcomes After Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Severe Coronary Artery Disease.
    Yamamoto K; Matsumura-Nakano Y; Shiomi H; Natsuaki M; Morimoto T; Kadota K; Tada T; Takeji Y; Yoshikawa Y; Imada K; Domei T; Kaneda K; Taniguchi R; Ehara N; Nawada R; Yamaji K; Kato E; Toyofuku M; Kanemitsu N; Shinoda E; Suwa S; Iwakura A; Tamura T; Soga Y; Inada T; Matsuda M; Koyama T; Aoyama T; Sato Y; Furukawa Y; Ando K; Yamazaki F; Komiya T; Minatoya K; Nakagawa Y; Kimura T;
    J Am Heart Assoc; 2021 Aug; 10(15):e021257. PubMed ID: 34323122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Outcomes of Percutaneous Coronary Intervention on Native Coronary Arteries Versus on Saphenous Venous Aorta Coronary Conduits in Patients With Low Left Ventricular Ejection Fraction and Impella Device Implantation Achieved or Attempted (from the PROTECT II Randomized Trial and the cVAD Registry).
    Shavelle DM; Banerjee S; Maini B; Schreiber TL; Kapasi N; O'Neill WW; Popma J; Matthews RV
    Am J Cardiol; 2018 Sep; 122(6):966-972. PubMed ID: 30057231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
    Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with reduced ejection fraction.
    Bianco V; Kilic A; Mulukutla S; Gleason TG; Kliner D; Allen CC; Habertheuer A; Aranda-Michel E; Humar R; Navid F; Wang Y; Sultan I
    J Thorac Cardiovasc Surg; 2021 Mar; 161(3):1022-1031.e5. PubMed ID: 33059935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypotheses, rationale, design, and methods for prognostic evaluation of a randomized comparison between patients with coronary artery disease associated with ischemic cardiomyopathy who undergo medical or surgical treatment: MASS-VI (HF).
    Rezende PC; Hueb W; Bocchi EA; Farkouh M; Junior CVS; Lima EG; Silva EER; Dallan LAO; Gaiotto FA; Garzillo CL; Rochitte CE; Nomura CH; Scudeler TL; Soares PR; Jatene FB; Ramires JAF; Filho RK
    Trials; 2020 Apr; 21(1):337. PubMed ID: 32299458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A single-center observational study on the efficacy of percutaneous coronary intervention for ischemic heart failure: A cohort study.
    Wang Z; Jin L; Zhou W; Lei D; Yan H; Yu H; Zeng Z; Zhu G; Zheng J; Dai Y; Wang H
    Medicine (Baltimore); 2018 Mar; 97(13):e0238. PubMed ID: 29595676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous Revascularization for Ischemic Ventricular Dysfunction: Rationale and Design of the REVIVED-BCIS2 Trial: Percutaneous Coronary Intervention for Ischemic Cardiomyopathy.
    Perera D; Clayton T; Petrie MC; Greenwood JP; O'Kane PD; Evans R; Sculpher M; Mcdonagh T; Gershlick A; de Belder M; Redwood S; Carr-White G; Marber M;
    JACC Heart Fail; 2018 Jun; 6(6):517-526. PubMed ID: 29852933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is the world ready for the STICH 3.0 trial?
    Vervoort D; Jolicoeur ME; Marquis-Gravel G; Fremes SE
    Curr Opin Cardiol; 2022 Nov; 37(6):474-480. PubMed ID: 36094455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
    Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
    Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator.
    Zishiri ET; Williams S; Cronin EM; Blackstone EH; Ellis SG; Roselli EE; Smedira NG; Gillinov AM; Glad JA; Tchou PJ; Szymkiewicz SJ; Chung MK
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):117-28. PubMed ID: 23275233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preferred Revascularization Strategies in Patients with Ischemic Heart Failure: A Meta-Analysis.
    Xiao J; Xu F; Yang CL; Chen WQ; Chen X; Zhang H; Wei ZJ; Liu JP
    Curr Med Sci; 2018 Oct; 38(5):776-784. PubMed ID: 30341512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severity of Remodeling, Myocardial Viability, and Survival in Ischemic LV Dysfunction After Surgical Revascularization.
    Bonow RO; Castelvecchio S; Panza JA; Berman DS; Velazquez EJ; Michler RE; She L; Holly TA; Desvigne-Nickens P; Kosevic D; Rajda M; Chrzanowski L; Deja M; Lee KL; White H; Oh JK; Doenst T; Hill JA; Rouleau JL; Menicanti L;
    JACC Cardiovasc Imaging; 2015 Oct; 8(10):1121-1129. PubMed ID: 26363840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized Clinical Trial of Surgical vs. Percutaneous vs. Hybrid Revascularization in Multivessel Coronary Artery Disease: Residual Myocardial Ischemia and Clinical Outcomes at One Year-Hybrid coronary REvascularization Versus Stenting or Surgery (HREVS).
    Ganyukov V; Kochergin N; Shilov A; Tarasov R; Skupien J; Szot W; Kokov A; Popov V; Kozyrin K; Barbarash O; Barbarash L; Musialek P
    J Interv Cardiol; 2020; 2020():5458064. PubMed ID: 31969796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants of Left Ventricular Systolic Function Improvement Following Coronary Artery Revascularization in Heart Failure Patients With Reduced Ejection Fraction (HFrEF).
    Adachi Y; Sakakura K; Wada H; Funayama H; Umemoto T; Fujita H; Momomura S
    Int Heart J; 2016 Sep; 57(5):565-72. PubMed ID: 27628418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.